China Pharma Holdings Inc

Research China Pharma Holdings Inc (CPHI) on Bullrun: market cap USD 35.25M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 35.25M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 4.14M-USD 3.19MUSD 88.94K-3.2%-0.74USD 345.11KUSD 1.44MUSD 22.74M
FY2024USD 4.53M-USD 4.74M-USD 444.47K-43.8%-2.71USD 626.88KUSD 1.14MUSD 7.75M
FY2023USD 7.01M-USD 3.08M-USD 711.20K-4.0%-0.91USD 1.42MUSD 1.13MUSD 7.45M
FY2022USD 8.10M-USD 3.97M-USD 811.51K-6.1%-3.78USD 2.03MUSD 10.57MUSD 4.29M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-25USD 35.25Mn/an/an/a
20252025-12-31USD 6.08Mn/an/an/a
20242024-12-31USD 7.50Mn/an/an/a
20232023-12-29USD 3.95Mn/an/an/a
20222022-12-30USD 5.17Mn/an/an/a
20212021-12-31USD 22.73Mn/an/an/a

About China Pharma Holdings Inc

China Pharma Holdings, Inc. develops, manufactures, and markets pharmaceutical products for human use in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is China Pharma Holdings Inc's market cap?

China Pharma Holdings Inc's market capitalization is USD 35.25M.

What does China Pharma Holdings Inc do?

China Pharma Holdings, Inc. develops, manufactures, and markets pharmaceutical products for human use in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.